BioCentury | Oct 20, 2014
Clinical News

Mibefradil dihydrochloride: Phase Ib started

...market due to the potential for multiple drug-drug interactions. In August, Tau Therapeutics LLC and Xdynia LLC...
BioCentury | Sep 29, 2014
Company News

Tau Therapeutics, Xdynia deal

...Tau Therapeutics and Xdynia merged to form Cavion LLC. In 2012, Tau launched Xdynia to develop...
...calcium channel inhibitor to treat neuropathic pain in 2015. Tau Therapeutics LLC , Charlottesville, Va. Xdynia LLC...
BioCentury | Jun 11, 2012
Emerging Company Profile

Xdynia: T type relief

...side effects ranging from somnolence and nausea to more serious risks including seizures and dependence. Xdynia's...
...persistent pain signals along the peripheral nerve to the brain. As a result, he believes Xdynia's...
...of Virginia , Charlottesville, Va. Xdynia LLC , Charlottesville, Va. Zalicus Inc. (NASDAQ:ZLCS), Cambridge, Mass. Sidebars Xdynia LLC...
BioCentury | Feb 27, 2012
Company News

Tau Therapeutics, Xdynia deal

...Cancer company Tau Therapeutics launched newco Xdynia to focus on the development of calcium channel T-type...
...of calcium channel T-type inhibitors for neuropathic pain. Tau licensed two libraries of compounds to Xdynia...
...former CMO of health IT company Clinixis Health Systems. Tau Therapeutics LLC , Charlottesville, Va. Xdynia LLC...
BioCentury | Feb 27, 2012
Financial News

Xdynia completes venture financing

Xdynia LLC , Charlottseville, Va. Business: Neurology Date completed: 2/23/12 Type: Venture financing Raised: $1.3 million Investors: Center for Innovative Technology GAP Fund; and other undisclosed investors Note: The newco raised $50,000 from the Center for...
BioCentury | Feb 24, 2012
Company News

Tau Therapeutics launches new pain company

...Cancer company Tau Therapeutics LLC (Charlottesville, Va.) launched newco Xdynia LLC to focus on the development of...
...of calcium channel T-type inhibitors for neuropathic pain. Tau licensed two libraries of compounds to Xdynia...
Items per page:
1 - 6 of 6
BioCentury | Oct 20, 2014
Clinical News

Mibefradil dihydrochloride: Phase Ib started

...market due to the potential for multiple drug-drug interactions. In August, Tau Therapeutics LLC and Xdynia LLC...
BioCentury | Sep 29, 2014
Company News

Tau Therapeutics, Xdynia deal

...Tau Therapeutics and Xdynia merged to form Cavion LLC. In 2012, Tau launched Xdynia to develop...
...calcium channel inhibitor to treat neuropathic pain in 2015. Tau Therapeutics LLC , Charlottesville, Va. Xdynia LLC...
BioCentury | Jun 11, 2012
Emerging Company Profile

Xdynia: T type relief

...side effects ranging from somnolence and nausea to more serious risks including seizures and dependence. Xdynia's...
...persistent pain signals along the peripheral nerve to the brain. As a result, he believes Xdynia's...
...of Virginia , Charlottesville, Va. Xdynia LLC , Charlottesville, Va. Zalicus Inc. (NASDAQ:ZLCS), Cambridge, Mass. Sidebars Xdynia LLC...
BioCentury | Feb 27, 2012
Company News

Tau Therapeutics, Xdynia deal

...Cancer company Tau Therapeutics launched newco Xdynia to focus on the development of calcium channel T-type...
...of calcium channel T-type inhibitors for neuropathic pain. Tau licensed two libraries of compounds to Xdynia...
...former CMO of health IT company Clinixis Health Systems. Tau Therapeutics LLC , Charlottesville, Va. Xdynia LLC...
BioCentury | Feb 27, 2012
Financial News

Xdynia completes venture financing

Xdynia LLC , Charlottseville, Va. Business: Neurology Date completed: 2/23/12 Type: Venture financing Raised: $1.3 million Investors: Center for Innovative Technology GAP Fund; and other undisclosed investors Note: The newco raised $50,000 from the Center for...
BioCentury | Feb 24, 2012
Company News

Tau Therapeutics launches new pain company

...Cancer company Tau Therapeutics LLC (Charlottesville, Va.) launched newco Xdynia LLC to focus on the development of...
...of calcium channel T-type inhibitors for neuropathic pain. Tau licensed two libraries of compounds to Xdynia...
Items per page:
1 - 6 of 6